MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer.
Li X, Ji Y, Han G, Li X, Fan Z, Li Y, Zhong Y, Cao J, Zhao J, Zhang M, Wen J, Goscinski MA, Nesland JM, Suo Z.
Li X, et al. Among authors: zhang m.
BMC Cancer. 2016 Nov 16;16(1):894. doi: 10.1186/s12885-016-2941-6.
BMC Cancer. 2016.
PMID: 27852261
Free PMC article.